Papers
1
Total Citations
3
H-Index
1
About
Dr. Shusheng Wang is a leading urologist whose research focuses on the evolution of treatment paradigms for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). His major contribution lies in synthesizing and advancing integrated management strategies that bridge pharmacological therapies, minimally invasive surgical therapies (MISTs), and traditional surgical approaches. His most-cited work, "Integrated management strategies for benign prostatic hyperplasia" (2025), has already garnered 3 citations, reflecting its timely impact on clinical decision-making. Dr. Wang’s research is notable for emphasizing patient-centered, stepwise care that balances efficacy, safety, and quality of life—a critical shift as the aging male population grows. By systematically evaluating emerging MISTs alongside established treatments, he provides a practical roadmap for urologists navigating an increasingly complex therapeutic landscape. His work is essential reading for clinicians and researchers seeking to optimize outcomes in BPH management, demonstrating a clear commitment to translating evidence into actionable clinical strategies.
Research Focus
Key Achievements
Top Papers
- 1Integrated management strategies for benign prostatic hyperplasia3 citations · 2025